Your email has been successfully added to our mailing list.

×
0 0 0.0106666666666667 0.0158666666666666 0.0186666666666667 0.0156650666666668 0.0304266666666667 0.0220266666666666
Stock impact report

U.S. FDA Grants BRUKINSA® (Zanubrutinib) Accelerated Approval in Relapsed or Refractory Marginal Zone Lymphoma

BeiGene, Ltd. - American Depositary Shares (BGNE) 
Last beigene, ltd. - american depositary shares earnings: 3/2 04:05 pm Check Earnings Report
Company Research Source: Business Wire
This marks the third FDA approval for BRUKINSA and first approval in marginal zone lymphomaTwenty percent of patients achieved complete remission with single-agent BRUKINSABRUKINSA was generally well-tolerated, consistent with its known safety profile CAMBRIDGE, Mass. & BEIJING--(BUSINESS WIRE)--BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a global biotechnology company focused on developing and commercializing innovative medicines worldwide, today announced that BRUKINSA® (zanubrutinib) has received accelerated approval from the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with relapsed or refractory (R/R) marginal zone lymphoma (MZL) who have received at least one anti-CD20-based regimen.This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210915005310/en/(Photo: Business Wire)This accelerated approval is based on overall response rate (ORR). Continued approval for this indication may be continge Show less Read more
Impact Snapshot
Event Time:
BGNE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
BGNE alerts

from News Quantified
Opt-in for
BGNE alerts

from News Quantified